VTVT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

vTv Therapeutics (VTVT) Ownership - Who owns vTv Therapeutics?

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

3980 Premier Drive

Phone

+1 336 841-0300

Employees

Web

https://www.vtvtherapeutics.com

Details

Group

Domestic Stock Funds

Fundamentals

VTVT

Capitalization

51.5M

P/E Ratio

N/A

Risk (Beta)

0.68

Dividend Yield

N/A

Total Cash

36.7M

Total Cash/Share

14.07

Total Debt

169K

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.18%

Revenue

1.02M

ROE

N/A

Book Value

12.2M

P/B Ratio

4.22

Cash Flow

N/A

Earnings

-3.2

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

32K

Current Ratio

7.34

Current Revenue Per Employee

1062.50

Dividends Per Share - Security

N/A

EBITDA

-22.52M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-74.92

Shares Held By Institutions

12M

Shares Outstanding - Current

2.61M

Total Liabilities

24M

Total Volume MTD

N/A

Value

N/A

Gain YTD

42.664

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage pharmaceutical holding company, which focuses on the discovery and development of human therapeutics

Industry Biotechnology